Centogene N.V. announced Andreas Busch?s and Holger Friedrich?s decision to resign from the Company?s Supervisory Board, effective December 12, 2023. Their respective resignations were not the result of any disagreement with the Company, and are in alignment with the Company?s previously announced intention on June 27, 2023, that two representatives from Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF), will join CENTOGENE?s Supervisory Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5151 USD | +3.02% | +16.54% | -57.08% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.08% | 14.94M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- CNTG Stock
- News Centogene N.V.
- Centogene N.V. Announces Changes to Supervisory Board